Zimmer Biomet has grown revenue 5.8% a year over three years and 2.9% a year over five, with earnings per share compounding at 20%. Revenue growth, 3-year annual rate: +5.8% (Medical Devices median +12%). Revenue growth, 5-year rate: +2.9%, growth has picked up over the last three years. Earnings per share, 3-year rate: +20%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 19, FY2007 to FY2025, as filed.

ZBHZimmer Biomet

Healthcare

$89.12-10% 1Y

$89.12

$79.5852 weeks$103.42

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−1.7 points).

1 to watch, 2 neutral

Revenue trend+9% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +3% a year.

Earnings trend+0% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−1.7 points operating

Trailing-twelve-month operating margin, 14.3% now against 16.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ZBH growing?

Zimmer Biomet has grown revenue 5.8% a year over three years and 2.9% a year over five, with earnings per share compounding at 20%.

+5.8%

Revenue growth, 3-year annual rate · Medical Devices median +12% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +2.9%
Revenue growth, 5-year rate · +5.8% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +20%
Earnings per share, 3-year rate · revenue +5.8% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed